STRUCTURE-ACTIVITY RELATIONSHIP OF FLAVONOIDS IN SUPPRESSING RAT-LIVER LIPID-PEROXIDATION

被引:17
作者
MIYAHARA, M
OHTAKA, H
KATAYAMA, H
TATSUMI, Y
MIYAICHI, Y
TOMIMORI, T
机构
[1] KANEBO CO LTD, NEW DRUG RES LABS, MIYAKOJIMA KU, OSAKA 534, JAPAN
[2] KOCHI MED SCH, DEPT MED, NANKOKU, KOCHI 783, JAPAN
[3] KANEBO CO LTD, TRADIT CHINESE MED RES LABS, MIYAKOJIMA KU, OSAKA 534, JAPAN
[4] HOKURIKU UNIV, SCH PHARM, KANAZAWA, ISHIKAWA 92011, JAPAN
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 1993年 / 113卷 / 02期
关键词
FLAVONOID; LIPID PEROXIDATION; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; ADAPTIVE LEAST-SQUARE METHOD; BIOMEMBRANE; BAICALEIN;
D O I
10.1248/yakushi1947.113.2_133
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
145 flavonoids were studied for their inhibitory effects on the iron-induced lipid peroxidation in mitochondria obtained from rat livers. Of these compounds tested, 30, 57, 59, 67, 70, 72, 77, 102 and 110 (ED50 less-than-or-equal-to 0.5 nmol/mg prot) showed distinctly more potent inhibitory activity than baicalein (ED50 less-than-or-equal-to 5 nmol/mg prot) and 59 and 72 (ED50 less-than-or-equal-to 0.05 nmol/mg prot) exhibited the most potent activity. In order to elucidate the relationships between substituents on the flavonoid skeleton and the biological activity, the quantitative structure-activity relationships (QSAR) were analyzed by the adaptive least-squares (ALS) method for 142 flavonoids. The analysis has shown that the presence of the 1,4- and 1,2-hydroquinon in A-ring and/or B-ring of flavonoids and hydrophobicity of the molecule are responsible for the in vitro inhibitory activity.
引用
收藏
页码:133 / 154
页数:22
相关论文
共 17 条
[1]  
Hansch C, 1979, SUBSTITUENT CONSTANT
[2]  
KIKUCHI Y, 1991, CHEM PHARM BULL, V39, P199
[3]  
KIKUCHI Y, 1991, CHEM PHARM BULL, V39, P1047, DOI 10.1248/cpb.39.1047
[4]  
KIZUCHI Y, 1991, CHEM PHARM BULL, V39, P1051
[5]  
KUZUCHI Y, 1991, CHEM PHARM BULL, V39, P1466
[6]   PARTITION COEFFICIENTS AND THEIR USES [J].
LEO, A ;
HANSCH, C ;
ELKINS, D .
CHEMICAL REVIEWS, 1971, 71 (06) :525-+
[7]  
MIYAICHI Y, 1988, Shoyakugaku Zasshi, V42, P216
[8]  
MIYAICHI Y, 1988, CHEM PHARM BULL, V36, P2371, DOI 10.1248/cpb.36.2371
[9]  
MIYAICHI Y, 1989, CHEM PHARM BULL, V37, P794
[10]  
MIYAICHI Y, 1987, CHEM PHARM BULL, V35, P3720